Treace Medical Concepts (TMCI) EBITDA Margin (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly EBITDA Margin came in at 32.96% in Q2 2026, up 286.0% on a YoY basis from 8.54% in Q2 2025, and up 9.37% quarter-over-quarter from 36.37% in Q1 2026.
Powered by 
Analysis
Treace Medical Concepts (TMCI) EBITDA Margin (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has reported EBITDA Margin for 7 consecutive years, with 32.96% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBITDA Margin rose 286.0% year-over-year to 32.96%; the trailing twelve-month figure through Jun 2026 stood at 26.17% (down 376.0% YoY), and the FY2025 full-year result was 25.46%, up 114.0% from the prior year.
- EBITDA Margin grew to 32.96% in Q2 2026 per TMCI's latest filing, from 36.37% in the prior quarter.
- Across five years, EBITDA Margin topped out at 0.3% in Q4 2024 and bottomed at 48.1% in Q2 2024.
- Historically, EBITDA Margin has averaged 28.99% across 5 years, with a median of 32.81% in 2026.
- The sharpest annual moves came in 2022 and 2025: EBITDA Margin plunged 2038 bps in 2022, then jumped 1228 bps in 2025.
- Over 5 years, EBITDA Margin stood at 7.03% in 2022, then tumbled by 55 bps to 10.9% in 2023, then surged by 97 bps to 0.3% in 2024, then tumbled by 3090 bps to 9.47% in 2025, then slumped by 248 bps to 32.96% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 32.96%, 36.37%, and 9.47% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 19.15% |
| 10 | Treace Medical Concepts | 294.68 Mn | 249.06 Mn | 35.61 Mn | -32.96% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -32.96% |
| Mar 31, 2026 | -36.37% |
| Dec 31, 2025 | -9.47% |
| Sep 30, 2025 | -31.22% |
| Jun 30, 2025 | -35.82% |
| Mar 31, 2025 | -29.64% |
| Dec 31, 2024 | -0.30% |
| Sep 30, 2024 | -33.57% |
| Jun 30, 2024 | -48.10% |
| Mar 31, 2024 | -37.11% |
| Dec 31, 2023 | -10.90% |
| Sep 30, 2023 | -43.72% |
| Jun 30, 2023 | -31.11% |
| Mar 31, 2023 | -32.65% |
| Dec 31, 2022 | -7.03% |
| Sep 30, 2022 | -34.24% |
| Jun 30, 2022 | -39.82% |
| Mar 31, 2022 | -27.87% |
| Dec 31, 2021 | -16.74% |
| Sep 30, 2021 | -25.26% |